Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	NF-kappa B signaling pathway	6/104	7.933426225711089e-10	6.981415078625759e-08	121.98979591836735	-343.35038043058773	IKBKG;LYN;NFKB1;RELA;TNFAIP3;TNFRSF1A
KEGG_2021_Human	TNF signaling pathway	5/112	1.1171098780714114e-07	4.91528346351421e-06	74.40186915887851	-210.55667833010622	IKBKG;NFKB1;RELA;TNFAIP3;TNFRSF1A
KEGG_2021_Human	Yersinia infection	5/137	3.070399768694536e-07	9.006505988170638e-06	60.121212121212125	-177.50304940933535	IKBKG;MEFV;NFKB1;RELA;WAS
KEGG_2021_Human	Adipocytokine signaling pathway	4/69	9.85085258926585e-07	1.8037190168236983e-05	82.08205128205128	-186.14595970778535	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	4/70	1.044163095458912e-06	1.8037190168236983e-05	80.82828282828282	-183.98664919066243	IKBKG;LYN;NFKB1;RELA
KEGG_2021_Human	NOD-like receptor signaling pathway	5/181	1.2298084205616124e-06	1.8037190168236983e-05	44.84090909090909	-138.94613864677578	IKBKG;MEFV;NFKB1;RELA;TNFAIP3
KEGG_2021_Human	B cell receptor signaling pathway	4/81	1.8822504670820177e-06	1.8404226789246395e-05	69.18614718614718	-163.26311048820392	IKBKG;LYN;NFKB1;RELA
KEGG_2021_Human	Chemokine signaling pathway	5/192	1.6475564077590864e-06	1.8404226789246395e-05	42.144385026737964	-131.72377772149218	IKBKG;LYN;NFKB1;RELA;WAS
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	5/193	1.6904863123009375e-06	1.8404226789246395e-05	41.91489361702128	-131.10253044151457	IKBKG;LYN;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Epstein-Barr virus infection	5/202	2.1180989596916704e-06	1.86392708452867e-05	39.954314720812185	-125.75142714199099	IKBKG;LYN;NFKB1;RELA;TNFAIP3
KEGG_2021_Human	Lipid and atherosclerosis	5/215	2.882246411730869e-06	2.1136473686026376e-05	37.41904761904762	-118.71127334987257	IKBKG;LYN;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Human immunodeficiency virus 1 infection	5/212	2.6891423738912685e-06	2.1136473686026376e-05	37.97584541062802	-120.26946900483341	AP1S3;IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	IL-17 signaling pathway	4/94	3.423271653145718e-06	2.3172915805909475e-05	59.096296296296295	-144.19803777501954	IKBKG;NFKB1;RELA;TNFAIP3
KEGG_2021_Human	Chagas disease	4/102	4.7476288106462685e-06	2.9842238238347974e-05	54.21768707482993	-134.5540755438832	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Toxoplasmosis	4/112	6.897261761044327e-06	4.046393566479339e-05	49.135802469135804	-124.17448810278691	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Osteoclast differentiation	4/127	1.1374005182336485e-05	6.255702850285066e-05	43.06233062330623	-111.27061146114511	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Fluid shear stress and atherosclerosis	4/139	1.6271599911932136e-05	7.955004401389044e-05	39.175308641975306	-102.69295126036515	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Measles	4/139	1.6271599911932136e-05	7.955004401389044e-05	39.175308641975306	-102.69295126036515	IKBKG;NFKB1;RELA;TNFAIP3
KEGG_2021_Human	Apoptosis	4/142	1.7706963311466067e-05	8.201119849521126e-05	38.309178743961354	-100.74461672219032	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Hepatitis C	4/157	2.633008128708365e-05	0.00011585235766316806	34.4880174291939	-91.97557482769783	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Influenza A	4/172	3.7714889820243616e-05	0.00015804334781816372	31.349206349206348	-84.54495262531024	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Cytosolic DNA-sensing pathway	3/63	5.21817057256637e-05	0.0002087268229026548	57.2	-103.63746645388204	IKBKG;NFKB1;RELA
KEGG_2021_Human	Pathogenic Escherichia coli infection	4/197	6.421891077355903e-05	0.00023546933950304978	27.202072538860104	-74.37625984844887	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Acute myeloid leukemia	3/67	6.278481738010982e-05	0.00023546933950304978	53.598214285714285	-98.46843432757142	IKBKG;NFKB1;RELA
KEGG_2021_Human	RIG-I-like receptor signaling pathway	3/70	7.160249860764975e-05	0.0002444069581717599	51.17910447761194	-94.92366080084827	IKBKG;NFKB1;RELA
KEGG_2021_Human	Viral carcinogenesis	4/203	7.221114673256542e-05	0.0002444069581717599	26.36180904522613	-72.26295411298177	IKBKG;LYN;NFKB1;RELA
KEGG_2021_Human	Pancreatic cancer	3/76	9.159620399517935e-05	0.0002878737839848494	46.93737769080235	-88.55605413655218	IKBKG;NFKB1;RELA
KEGG_2021_Human	Chronic myeloid leukemia	3/76	9.159620399517935e-05	0.0002878737839848494	46.93737769080235	-88.55605413655218	IKBKG;NFKB1;RELA
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	4/219	9.708345438267137e-05	0.0002945980684715545	24.350387596899225	-67.12577033726024	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Human cytomegalovirus infection	4/225	0.00010785574304042276	0.00031637684625190676	23.671191553544496	-65.36509727839072	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Coronavirus disease	4/232	0.00012150057084905025	0.0003449048462811749	22.923976608187136	-63.412309433922275	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Th1 and Th2 cell differentiation	3/92	0.00016192103282048912	0.00039580696911675116	38.42215088282504	-75.11644417571499	IKBKG;NFKB1;RELA
KEGG_2021_Human	Small cell lung cancer	3/92	0.00016192103282048912	0.00039580696911675116	38.42215088282504	-75.11644417571499	IKBKG;NFKB1;RELA
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	3/89	0.0001467151296543735	0.00039580696911675116	39.777408637873755	-77.31969343552903	IKBKG;NFKB1;RELA
KEGG_2021_Human	Shigellosis	4/246	0.00015252097444894315	0.00039580696911675116	21.55922865013774	-59.801482853342776	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Salmonella infection	4/249	0.00015985480003693624	0.00039580696911675116	21.287074829931974	-59.07439560833883	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Prostate cancer	3/97	0.00018948670381727933	0.00045067107934920487	36.35562310030395	-71.7056117119453	IKBKG;NFKB1;RELA
KEGG_2021_Human	T cell receptor signaling pathway	3/104	0.0002329673917108638	0.0005125282617639004	33.806223479490804	-67.40758155759835	IKBKG;NFKB1;RELA
KEGG_2021_Human	Toll-like receptor signaling pathway	3/104	0.0002329673917108638	0.0005125282617639004	33.806223479490804	-67.40758155759835	IKBKG;NFKB1;RELA
KEGG_2021_Human	C-type lectin receptor signaling pathway	3/104	0.0002329673917108638	0.0005125282617639004	33.806223479490804	-67.40758155759835	IKBKG;NFKB1;RELA
KEGG_2021_Human	Th17 cell differentiation	3/107	0.0002534260244380865	0.0005439387841597955	32.81868131868132	-65.71442008901244	IKBKG;NFKB1;RELA
KEGG_2021_Human	Insulin resistance	3/108	0.00026049631963660937	0.0005458018125719434	32.50204081632653	-65.16806085544759	NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	MAPK signaling pathway	4/294	0.0003034351122757725	0.0006209834855876275	17.880459770114943	-49.762697732575255	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Sphingolipid signaling pathway	3/119	0.0003468783323520502	0.0006937566647041004	29.379310344827587	-59.68521503911596	NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Human papillomavirus infection	4/331	0.0004777466484480537	0.0009342601125206383	15.781855249745158	-43.81753827074924	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Non-alcoholic fatty liver disease	3/155	0.0007531180482518497	0.001440747570568756	22.31954887218045	-46.57552582678881	NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Hepatitis B	3/162	0.000856615716023289	0.001603876234256371	21.318059299191376	-44.62403509135876	IKBKG;NFKB1;RELA
KEGG_2021_Human	Tuberculosis	3/180	0.0011634285381276748	0.0021329523199007374	19.106537530266344	-40.222430877266724	NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Cocaine addiction	2/49	0.0015725648721553246	0.0028241981377483383	42.66489361702128	-51.011826705781694	NFKB1;RELA
KEGG_2021_Human	Legionellosis	2/57	0.0021229405609363423	0.003736375387247962	36.42272727272727	-44.890022889750604	NFKB1;RELA
KEGG_2021_Human	Herpes simplex virus 1 infection	4/498	0.002222912628244597	0.0038356139467749907	10.22132253711201	-27.191293900864785	IKBKG;NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Ras signaling pathway	3/232	0.0024164136009215383	0.004089315324636449	14.670617592014972	-30.966105875434415	IKBKG;NFKB1;RELA
KEGG_2021_Human	Inflammatory bowel disease	2/65	0.002752148243719554	0.0045696046310815235	31.765873015873016	-40.07734547796954	NFKB1;RELA
KEGG_2021_Human	Prolactin signaling pathway	2/70	0.0031848593502604382	0.0051901411633873806	29.41176470588235	-37.553176952571945	NFKB1;RELA
KEGG_2021_Human	Pertussis	2/76	0.0037436519554145367	0.005989843128663259	27.006756756756758	-34.90410589940028	NFKB1;RELA
KEGG_2021_Human	Leishmaniasis	2/77	0.0038409427449733026	0.006035767170672333	26.643333333333334	-34.49723066158141	NFKB1;RELA
KEGG_2021_Human	Fc gamma R-mediated phagocytosis	2/97	0.006031622120792857	0.009311978011048622	20.981578947368423	-27.909669646620806	LYN;WAS
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.0097100083265232	20.331632653061224	-27.120602948412195	NFKB1;RELA
KEGG_2021_Human	Longevity regulating pathway	2/102	0.006650847322673755	0.009754576073254842	19.92	-26.61700675496218	NFKB1;RELA
KEGG_2021_Human	Amoebiasis	2/102	0.006650847322673755	0.009754576073254842	19.92	-26.61700675496218	NFKB1;RELA
KEGG_2021_Human	HIF-1 signaling pathway	2/109	0.007564767477927373	0.010913107181272275	18.600467289719628	-24.98176436194636	NFKB1;RELA
KEGG_2021_Human	PI3K-Akt signaling pathway	3/354	0.007955391465782094	0.011291523370787489	9.422466422466423	-19.140881053489387	IKBKG;NFKB1;RELA
KEGG_2021_Human	Neurotrophin signaling pathway	2/119	0.008964014539605185	0.012325519991957128	16.98931623931624	-22.939511285821055	NFKB1;RELA
KEGG_2021_Human	Alzheimer disease	3/369	0.008924054845697141	0.012325519991957128	9.018735362997658	-18.187178129854335	NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Relaxin signaling pathway	2/129	0.010471317399144716	0.014176552786534385	15.631889763779528	-21.1770620526928	NFKB1;RELA
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.020083599143779697	12.847402597402597	-17.429441058365175	NFKB1;RELA
KEGG_2021_Human	Necroptosis	2/159	0.015618487202540639	0.020513833937665316	12.597133757961783	-17.083187709957596	TNFAIP3;TNFRSF1A
KEGG_2021_Human	Pathways of neurodegeneration	3/475	0.017772166326566263	0.02299927406967399	6.897094430992736	-13.07371705691191	NFKB1;RELA;TNFRSF1A
KEGG_2021_Human	Neutrophil extracellular trap formation	2/189	0.02165639204960556	0.027619746382105643	10.536096256684491	-14.167050995225416	NFKB1;RELA
KEGG_2021_Human	Transcriptional misregulation in cancer	2/192	0.0223068963273402	0.028042955382941968	10.365789473684211	-13.920708621090329	NFKB1;RELA
KEGG_2021_Human	Pathways in cancer	3/531	0.02393281759639253	0.029663210542007646	6.12012987012987	-11.164029011261546	IKBKG;NFKB1;RELA
KEGG_2021_Human	Diabetic cardiomyopathy	2/203	0.024762333575826773	0.030265074370454944	9.784825870646767	-13.073912909097736	NFKB1;RELA
KEGG_2021_Human	cAMP signaling pathway	2/216	0.027803609837697526	0.0335166803522929	9.175233644859814	-12.174459052502558	NFKB1;RELA
KEGG_2021_Human	Chemical carcinogenesis	2/239	0.03354092254711208	0.039886502488457605	8.26054852320675	-10.803362590978235	NFKB1;RELA
KEGG_2021_Human	Primary immunodeficiency	1/38	0.046083072411820386	0.05407080496320259	24.117117117117118	-13.560364723090352	IKBKG
KEGG_2021_Human	Long-term depression	1/60	0.07188046794101291	0.08323001551064653	15.08286252354049	-8.981081638876871	LYN
KEGG_2021_Human	Mitophagy	1/68	0.0811045146521906	0.0915025293511894	13.26865671641791	-7.96724592924887	RELA
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.0915025293511894	13.26865671641791	-7.96724592924887	LYN
KEGG_2021_Human	Adherens junction	1/71	0.08454220466511847	0.09417359507000539	12.695238095238095	-7.638591016595616	WAS
KEGG_2021_Human	Choline metabolism in cancer	1/98	0.11496450084552494	0.12646095093007745	9.130584192439862	-5.49346810373269	WAS
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.1273081702111603	8.94388327721661	-5.375723879218761	TNFRSF1A
KEGG_2021_Human	Platelet activation	1/124	0.14339691916847833	0.15388937666861088	7.177055103884372	-4.231046804704064	LYN
KEGG_2021_Human	Lysosome	1/128	0.14769739689308778	0.15659483044086414	6.94750656167979	-4.078087345546839	AP1S3
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.1835220212187908	5.74800290486565	-3.2620286219941206	TNFRSF1A
KEGG_2021_Human	Tight junction	1/169	0.19067020323006928	0.19739973981465994	5.224867724867725	-2.8972129419331236	WAS
KEGG_2021_Human	Cytokine-cytokine receptor interaction	1/295	0.310808292768788	0.3180363926006203	2.9380196523053668	-1.2513063817932166	TNFRSF1A
KEGG_2021_Human	MicroRNAs in cancer	1/310	0.3239838755949599	0.3277078281880054	2.7900035958288387	-1.143955577607994	NFKB1
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3695602254440061	2.3584328129782675	-0.8341701676241932	TNFRSF1A
